SecBot SecBot
SECBOTREPLAY Home › Report › PHAR

PHAR · Pharming Group N.V

Pharming Group N.V. · 6-K filed May 28, 2026 at 10:52 ET

At the news

NEUTRALIMPACT 3/10

6-K filed May 28, 2026 at 10:52 ET

Pharming Group N.V. filed a 6-K reporting the results of its 2026 Annual General Meeting of Shareholders, where shareholders approved all proposals including the appointment of KPMG Accountants N.V. as the new external auditor for 2026-2028, replacing Deloitte. The filing also notes the renewal of authorizations for the Board to issue and repurchase shares. No financial results or material operational updates were disclosed.

  • Shareholders approved all AGM proposals on May 28, 2026.
  • KPMG Accountants N.V. appointed as external auditor for fiscal years 2026-2028, replacing Deloitte.
  • Deloitte's reports for 2024 and 2025 contained no adverse opinion or disclaimer of opinion.
  • No disagreements or reportable events occurred between the company and Deloitte during the relevant periods, except for previously disclosed material weaknesses in internal control over financial reporting.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access